Biotech · Private company
Scioderm, Inc.
Track this companyFree. Adds Scioderm, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- SD-101-6.0 creamPhase 3 · Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
- SD-101 dermal cream (3%)Phase 2 · Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
- SD-101 Dermal Cream (6%)Phase 2 · Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle (SD-101 0%)Phase 2 · Epidermolysis BullosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis BullosaPHASE3 · TERMINATED · started Jun 9, 2015ClinicalTrials.gov NCT02670330 · fetched Nov 12, 2026
- ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis BullosaPHASE3 · COMPLETED · started Mar 11, 2015ClinicalTrials.gov NCT02384460 · fetched Nov 12, 2026
- Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis BullosaPHASE2 · TERMINATED · started Mar 26, 2014ClinicalTrials.gov NCT02090283 · fetched Nov 12, 2026
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis BullosaPHASE2 · COMPLETED · started Jan 6, 2014ClinicalTrials.gov NCT02014376 · fetched Nov 12, 2026